Catalog No. :
|
CLA1004 |
Product Name :
|
Aflibercept biosimilar |
CAS No. :
|
862111-32-8 |
Synonyms :
|
VEGF Trap; VEGF-TRAPR1R2; VEGF-trapR1 |
Chemical Name :
|
|
Molecular Formula :
|
|
Molecular Weight :
|
|
Molecular Structure :
|
|
Appearance :
|
Colorless to light yellow liquid |
Specification :
|
95+% |
Application :
|
VEGFR/PDGFR |
Registration :
|
|
Storage Condition :
|
- 20℃ 3 years,-80°C for long term |
Aflibercept biosimilar is a recombinant fusion protein consisting of portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc portion of human IgG1 formulated as an iso-osmotic solution for intravitreal administration. Aflibercept biosimilar is a dimeric glycoprotein with a protein molecular weight of 97 kilodaltons (kDa) and contains glycosylation, constituting an additional 15% of the total molecular mass, resulting in a total molecular weight of 115 kDa. Aflibercept biosimilar is produced in recombinant Chinese hamster ovary (CHO) cells.
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.